Scott Westhouse, DO
Ophthalmology · Grand Rapids, MINPI 1306016977
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $103,288 of the $137,553 with a category attached, or 75.1%. Regeneron Healthcare Solutions, Inc. accounts for 80.2% of it on its own, with 26 other manufacturers making up the rest. Among ophthalmology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 312 payments — averaging $440.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$110K
- Alimera Sciences, Inc.$7K
- Genentech USA, Inc.$6K
- Novartis$4K
- Apellis Pharmaceuticals, Inc.$4K
- US Retina LLC$2K
- plus $3K from 21 others
Across 96 payments — averaging $4033.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$373K
- Regeneron$9K
- Roche TCRC, Inc.$5K
What the payments were for
- Consulting fees$10,8258%
- Speaking & faculty fees$103,28875%
- Travel & lodging$4,8804%
- Food & beverage$16,20812%
- Ownership interest$2,3522%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 125 | $110,319 |
| Alimera Sciences, Inc. | 21 | $7,097 |
| Genentech USA, Inc. | 31 | $6,055 |
| Novartis | 14 | $4,396 |
| Apellis Pharmaceuticals, Inc. | 20 | $4,036 |
| US Retina LLC | 5 | $2,352 |
| Astellas Pharma US Inc | 17 | $780 |
| AbbVie(2 entities) | 25 | $742 |
| Coherus Oncology, Inc. | 7 | $375 |
| Regeneron | 2 | $237 |
| Bausch & Lomb Americas Inc. | 5 | $192 |
| Eyepoint US, Inc. | 7 | $155 |
| Mallinckrodt Enterprises LLC | 5 | $108 |
| ANI Pharmaceuticals, Inc. | 3 | $83 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $79 |
| Mallinckrodt Hospital Products Inc. | 3 | $69 |
| Hoffmann-la Roche Limited | 1 | $64 |
| Genentech, Inc. | 1 | $59 |
| Amgen(2 entities) | 3 | $55 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $54 |
| Sandoz | 2 | $53 |
| Oyster Point Pharma, Inc. | 2 | $41 |
| Ocular Therapeutix, Inc. | 2 | $38 |
| Biogen | 2 | $38 |
| Biotissue Holdings Inc. | 2 | $31 |
| Dompe US, Inc. | 1 | $27 |
| Neurotech Pharmaceuticals, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$137,553 in reported general payments places this provider in the 95th percentile of 674 ophthalmology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 223 | $7,941 |
| Difluprednate | 41 | $5,283 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 18 | $3,460 |
| Bromfenac Sodium | 26 | $2,980 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 45 | $1,004 |
| ValacyclovirValacyclovir Hcl | 17 | $961 |
| Timolol Maleate | 85 | $954 |
| Brimonidine Tartrate | 46 | $697 |
| Acetazolamide | 14 | $505 |
| Dorzolamide Hcl | 27 | $490 |
| Latanoprost | 28 | $453 |
| Gentamicin Sulfate | 77 | $450 |
| Prednisone | 27 | $102 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Grand Rapids
- Austen KnappGrand Rapids$16K
- Marcus MuallemGrand Rapids$15K
- Manjool ShahAnn Arbor$609K
- Gregory KatzYpsilanti$401K
- Timothy PageBirmingham$250K
- David ZacksAnn Arbor$177K
- Bret HughesDetroit$123K
- Pradeepa YoganathanDetroit$115K
- Jason MillerAnn Arbor$104K
- David TukelDearborn$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.